North America Alfacalcidol Market Analysis 2034: Rising Demand for Vitamin D Analog Therapies
The North America Alfacalcidol Market is projected to grow steadily through 2034, driven by the increasing prevalence of vitamin D deficiency, chronic kidney diseases, and disorders affecting mineral and bone metabolism. As an active vitamin D analog, alfacalcidol helps regulate calcium and phosphate levels and supports bone health in patients with impaired vitamin D metabolism. Advanced...
0 Yorumlar 0 hisse senetleri 186 Views 0 önizleme